SPRING PHARMACEUTICAL GROUP, INC. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $64.9M
- Net Income/Loss (FY2017)
- $11.7M
- Total Assets (FY2017)
- $110.1M
- Total Equity (FY2017)
- $108.2M
- Cash Flows from Operating Activities (FY2017)
- $17.9M
Source: SPRING PHARMACEUTICAL GROUP, INC. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
